Health
7.2
Eli Lilly wins China approval for first oral GLP-1 weight-loss drug, beating Novo Nordisk
Published 4 h ago2 sourcesEvidence: Reported
SeverityHighSouth China Morning PostLow-rated sourceCN · US
HealthReportedMedium
5.4
Poland obesity drug market worth 1.5B zł; pharma funds campaigns, reimbursement push
Polish obesity drug market is valued at 1.5B zł annually, with pharmaceutical companies spending 25M zł in 2025 on collaborations with doctors and patient groups. Reimbursement applications could cost the state budget 1.4B zł over coming years, raising concerns about industry influence on policy.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Score Breakdown
Mosaic Score5.4
Model confidence0.5
Significance0.5
Source credibility0.3
Related signals
8 foundHealth
5.3
Retatrutide phase 3 trials show reduced pain, improved mobility in knee osteoarthritis with obesity
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateLa Nación (Argentina)Low-rated source
Health
5.1
Poland Drops Breastfeeding from National Health Program, Experts Warn of Neglect
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateOKO.pressPL
Health
4.9
Nigeria grants N24bn tax waivers to drugmakers to boost local production
Published 1 d ago1 sourceEvidence: Reported
SeverityModeratePremium TimesLow-rated sourceNG
Health
2.1
Poland reclassifies Ibum Forte to prescription-only, renamed Ibum Med
Published 2 d ago1 sourceEvidence: Reported
RzeczpospolitaLow-rated sourcePL
Health
2.1
Poland reclassifies Ibum Forte 400 mg to prescription-only
Published 23 h ago1 sourceEvidence: Reported
RzeczpospolitaLow-rated sourcePL
Defense
9.1
US final decision on permanent Poland base expected December; Kosiniak-Kamysz signals approval
Published 2 d ago5 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyGazeta WyborczaPL · US
Justice
9.1
Polish investigators probe far-right links in Krakow mass shooting that killed 6
Published 2 d ago6 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyAnadolu Agency ENPL · NO